Analyzing...
Loading company...
No significant concerns identified
Nothing flagged for monitoring
“Services business in Healthcare — Hospitals & Diagnostics.”
₹3,035 Cr service revenue.
Employee costs at 16.5% of revenue — primary cost driver.
“all hospitals within the first twelve months will become EBITDA neutral”
“Core clusters Telangana and Andhra Pradesh are at 25-50% margin, sustainable. Margins improving over last couple quarters”
“Andhra region healthy growth rate in high teens, mid teens”
| KPI | Company | Sector Median |
|---|---|---|
| ROE | 13.3%▲ | 7.9% |
| ROCE | 10.5%▼ | 11.3% |
| Net Margin | 8.3%▼ | 9.3% |
| EBITDA Margin | 22.6%▲ | 21.9% |
| Debt To Equity | 1.40x▲ | 0.16x |
| Rev Growth 3yr | 22.4%▲ | 12.4% |
| EPS Growth 3yr | 5.0%▼ | 11.8% |
| Employee Cost Ratio | 16.50x | - |
Historical valuation data not available.
| (₹ Cr) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Revenue | ₹3,627 Cr +19.5% | ₹3,035 Cr +21.5% | ₹2,498 Cr +13.7% | ₹2,198 Cr +33.1% | ₹1,651 Cr +24.1% | ₹1,330 Cr |
| Other Income | ₹21 Cr -34.2% | ₹32 Cr +144.3% | ₹13 Cr -49.5% | ₹26 Cr +27.7% | ₹20 Cr +99.3% | ₹10 Cr |
| Total Income | ₹3,648 Cr +18.9% | ₹3,067 Cr +22.1% | ₹2,511 Cr +12.9% | ₹2,224 Cr +33.1% | ₹1,671 Cr +24.7% | ₹1,340 Cr |
| COGS | ₹743 Cr +18.6% | ₹627 Cr +18.2% | ₹530 Cr +10.3% | ₹481 Cr +35.3% | ₹355 Cr +22.9% | ₹289 Cr |
| ₹3,245 Cr +28.8% | ₹2,520 Cr +22.8% | ₹2,051 Cr +17.0% | ₹1,753 Cr +43.3% | ₹1,224 Cr +15.3% | ₹1,061 Cr | |
| Profit Before Tax | ₹413 Cr -26.0% | ₹558 Cr +21.4% | ₹460 Cr -5.2% | ₹485 Cr +8.4% | ₹447 Cr +60.3% | ₹279 Cr |
| Exceptional Items | ₹11 Cr -2.8% | ₹11 Cr | ₹0.00 Cr -100.0% | ₹15 Cr | ₹0.00 Cr | ₹0.00 Cr |
| ₹98 Cr -31.5% | ₹143 Cr +15.9% | ₹124 Cr +3.8% | ₹119 Cr +4.2% | ₹114 Cr +55.5% | ₹74 Cr | |
| Net Profit | ₹315 Cr -24.1% | ₹415 Cr +23.4% | ₹336 Cr -8.1% | ₹366 Cr +6.4% | ₹344 Cr +67.3% | ₹205 Cr |
| Profit (Owners) | ₹301 Cr -21.7% | ₹385 Cr +24.0% | ₹310 Cr -7.8% | ₹336 Cr +1.1% | ₹333 Cr +65.3% | ₹201 Cr |
| Minority Interest | ₹14 Cr -52.5% | ₹30 Cr +17.2% | ₹26 Cr -12.3% | ₹29 Cr +165.4% | ₹11 Cr +160.8% | ₹4 Cr |
| Other Comprehensive Income | ₹0.60 Cr ↑ Recovery | (₹2 Cr) ↓ Decline | ₹0.33 Cr -61.7% | ₹0.85 Cr +609.2% | ₹0.12 Cr ↑ Recovery | (₹0.46 Cr) |
| EPS | ₹7.51 | ₹9.61 | ₹7.75 | ₹8.41 | ₹8.31 | ₹54551.50 |
| Diluted Shares | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹40 Cr | ₹38 Cr |
No related party data available for this company.
This section will be populated when data becomes available.
Disclaimer · The Stock Filter is an information platform, not a SEBI-registered investment adviser. All data, scores, and narratives are generated from public filings and AI analysis — they do not constitute investment advice, recommendations, or endorsements. Always consult a qualified financial adviser before making investment decisions. Past performance does not guarantee future results.
Audited Standalone and Consolidated Financial Statements for the Financial Year ended 31st March 2026.
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on Jun 13, 2026.
Dr. Bhaskara Rao Bollineni has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) read with Regulation 31(5) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2...
Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
Krishna Institute of Medical Sciences Limited has informed the Exchange about Transcript
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding a press release dated May 16, 2026, titled "Press Release".
Krishna Institute of Medical Sciences Limited has informed the Exchange about Investor Presentation
Krishna Institute of Medical Sciences Limited has informed the Exchange about Copy of Newspaper Publication
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding 'Intimation of entering into Memorandum of Understanding for Strategic Clinical Collaboration'.
Krishna Institute of Medical Sciences Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regarding voting results.
Krishna Institute of Medical Sciences Limited has informed the Exchange about Copy of Newspaper Publication-Notice of Postal Ballot
Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
Krishna Institute of Medical Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on March 11, 2026.
Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
Krishna Institute of Medical Sciences Limited has informed the Exchange about Schedule of meet
No dividend history available for this company.